Monro, Inc (MNRO) Misses Q2 EPS by 9c
Tweet
Share
E-mail
Get Alerts MNRO Hot Sheet
Price: $11.48 --0%
Financial Fact:
Operating, selling, general and administrative expenses: 68.07M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Operating, selling, general and administrative expenses: 68.07M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Monro, Inc (NASDAQ: MNRO) reported Q2 EPS of $0.17, $0.09 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $301.39 million versus the consensus estimate of $300.06 million.
For earnings history and earnings-related data on Monro, Inc (MNRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
